Breaking Pancreatic Cancer’s Shield | Science News

Scientists may have uncovered a game-changing strategy to tackle pancreatic cancer’s toughest defenses: blocking the IL1RAP receptor, a key hub that fuels tumor survival and immune evasion. Early lab results show this approach dismantles protective networks, revs up T cells, and could dramatically boost the effectiveness of chemo and immunotherapy. A new clinical trial is now set to test this combo therapy in operable patients before surgery—aiming to reprogram the tumor’s environment so existing treatments can finally land a decisive blow. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6147ab73a8288848